CIPLASTAVIR (ZERIT) INDICATIONS
Ciplastavir is an antiviral medication that prevents human immunodeficiency virus (HIV) cells from multiplying in your body. HIV attacks the immune system, slowly destroying the body's ability to fight off infection.
Ciplastavir is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). It is not a cure for HIV or AIDS.
Ciplastavir may also be used for other purposes not listed.
CIPLASTAVIR (ZERIT) INSTRUCTIONS
Take Ciplastavir exactly as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor. Follow the directions on your prescription label.
Ciplastavir comes with patient instructions for safe and effective use. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.
Take Ciplastavir with a full glass of water.
Ciplastavir can be taken with or without food.
CIPLASTAVIR (ZERIT) STORAGE
The recommended dose for adults is 40 mg twice daily for those weighing 60 kg or more and 30 mg twice daily if less than 60 kg. Children weighing less than 30 kg should receive 1 mg/kg. Children weighing 30 kg or more should be treated like adults. Ciplastavir may be administered without regard to meals.
CIPLASTAVIR (ZERIT) STORAGE
Store Ciplastavir at room temperature away from moisture and heat. Keep the bottle tightly closed.
Throw away any leftover medication after 30 days. Throw away any unused or expired Ciplastavir in a closed container or sealed bag. You may also ask your pharmacist where to locate a community pharmaceutical take-back disposal program.
CIPLASTAVIR (ZERIT) MORE INFO:
Active Ingredient: stavudine
Do NOT use Ciplastavir if:
you are allergic to stavudine.
If you have certain conditions, you may need a dose adjustment or special tests to safely take this medication. Before taking Ciplastavir, tell your doctor if you are allergic to any drugs, or if you have:
kidney disease;
liver disease;
diabetes; or
a history of pancreatitis.
Some people have developed a life-threatening condition called lactic acidosis while taking Ciplastavir. You may be more likely to develop lactic acidosis if you are overweight or have liver disease, if you are a woman, or if you have taken certain HIV or AIDS medications for a long time. Talk with your doctor about your individual risk.
Ciplastavir can also cause severe or life-threatening effects on your liver or pancreas. Call your doctor at once if you have any of these symptoms while taking Ciplastavir: severe pain in your upper stomach spreading to your back, fast heart rate, nausea and vomiting, diarrhea, loss of appetite, low fever, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes).
FDA pregnancy category C. It is not known whether Ciplastavir is harmful to an unborn baby. HIV can be passed to the baby if the mother is not properly treated during pregnancy. Ciplastavir may also be more likely to cause lactic acidosis in a pregnant woman. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Take all of your HIV medicines as directed to control your infection while you are pregnant.
You should not breast-feed while you are using Ciplastavir. Women with HIV or AIDS should not breast-feed at all. Even if your baby is born without HIV, you may still pass the virus to the baby in your breast milk.
Important safety information:
Before taking Ciplastavir, tell your doctor if you are using any of the following drugs:
didanosine (Videx);
doxorubicin (Adriamycin);
hydroxyurea (Droxia, Hydrea);
interferon-alfa (Roferon, Intron, Rebetron);
ribavirin (Rebetol, Ribasphere, Copegus Virazole); or
zidovudine (Retrovir).
This list is not complete and there may be other drugs that can interact with Ciplastavir. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.
Seek emergency medical attention if you think you have used too much of this medicine. Overdose symptoms may include numbness, burning, pain, or tingly feeling, nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes).
Avoid drinking alcohol while taking Ciplastavir. Alcohol may increase the risk of damage to the pancreas and/or liver.
Taking Ciplastavir will not prevent you from passing HIV to other people through unprotected sex or sharing of needles. Talk with your doctor about safe methods of preventing HIV transmission during sex. Sharing drug or medicine needles is never safe, even for a healthy person.
Stop using Ciplastavir and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these other serious side effects:
liver damage - nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
lactic acidosis - muscle pain or weakness, numb or cold feeling in your arms and legs, trouble breathing, nausea with vomiting, fast or uneven heart rate, dizziness, or feeling very weak or tired;
pancreatitis - severe pain in your upper stomach spreading to your back, nausea and vomiting, fast heart rate;
peripheral neuropathy - numbness, tingling, or pain in your hands or feet;
high blood sugar - increased thirst, fruity breath odor, increased urination, drowsiness, dry skin, nausea, and vomiting; or
any signs of infection such as fever, chills, sore throat, flu symptoms, easy bruising or bleeding (nosebleeds, bleeding gums), mouth sores, or unusual weakness.
Less serious Ciplastavir side effects may include:
diarrhea;
muscle pain;
headache;
mild skin rash; or
changes in the shape or location of body fat (especially in your arms, legs, face, neck, breasts, and trunk).
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect.